Developers and investors

We caught up with Brady Welch co-founder of Slate Asset Management, a global alternative investment platform headquartered in Toronto.

Rob Beacroft believes life sciences real estate will not remain niche but will become an increasingly important part of investors’ allocations to alternatives.

Tell us a bit about yourself and your background. Where did you work prior to your current role? My background

British Land is increasing its exposure to the life sciences real estate sector and has a programme to deliver 1.

DRIVEN is a specialist investor, developer and operator for the science and innovation sector. We caught up with Toğrul

We spoke with George Fraser-Harding, head of European Funds at Aviva Investors, about life sciences real estate. Aviva Investors has